Stay updated on Medicenna Therapeutics Press Releases
Sign up to get notified when there's something new on the Medicenna Therapeutics Press Releases page.

Latest updates to the Medicenna Therapeutics Press Releases page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new News Release entry announcing Medicenna's presentation at the H.C. Wainwright 28th Annual Global Investment Conference on September 3, 2026 has been added, and the May 22, 2026 release about the prospectus supplement and investment term sheet has been removed.SummaryDifference4%

- Check37 days agoChange DetectedThe page now includes a new August 14, 2026 news release on Q1 FY2027 financial results and upcoming conferences, and it removes the May 19, 2026 item detailing the finalization of the terms of its public offering.SummaryDifference3%

- Check87 days agoChange DetectedAdded a June 26, 2026 News Release titled 'Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights,' indicating new financial results are now published on the page. Removed the May 13, 2026 News Release 'Medicenna Announces the Launch of a Marketed Public Offering of Securities,' updating the feed to reflect that the offering announcement is no longer listed.SummaryDifference3%

- Check101 days agoChange DetectedAdds a June 11, 2026 item noting Medicenna's strengthened patent estate across IL-2, IL-4 and IL-13 platforms. Removes the May 12, 2026 item announcing the first patient dosed in the NEO-CYT study for MDNA11 in neoadjuvant melanoma.SummaryDifference3%

- Check109 days agoChange DetectedA June 3, 2026 news release about MDNA11 in earlier-line melanoma is added; the April 30, 2026 NEOCYT ASCO release is removed.SummaryDifference3%

- Check116 days agoChange DetectedTwo new news items were added to the News Releases page: May 28, 2026, announcing the closing of a public offering of units to raise CDN$4.44 million. May 22, 2026, announcing the filing of a prospectus supplement and investment term sheet.SummaryDifference4%

Stay in the know with updates to Medicenna Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Medicenna Therapeutics Press Releases page.